🇺🇸 FDA
Patent

US 7256028

Methods for screening compounds that modulate lipid metabolism

granted A61PA61P11/00A61P17/06

Quick answer

US patent 7256028 (Methods for screening compounds that modulate lipid metabolism) held by Xenon Genetics Inc. expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Genetics Inc.
Grant date
Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P11/00, A61P17/06, A61P19/02, A61P25/00